Liptak Vincent Paul
All 5 shown
- BlossomHill Therapeutics, Inc. General counsel—Conversion
- BlossomHill Therapeutics, Inc. General counsel—Conversion
- BlossomHill Therapeutics, Inc. General counsel$35,200Open-market buy
- BlossomHill Therapeutics, Inc. General counsel$39,500Open-market buy
- BlossomHill Therapeutics, Inc. General counsel46,561 sharesGrant